Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Hemorrhagic stroke
  • Track 1-2Thrombotic stroke
  • Track 1-3Intracerebral hemorrhage
  • Track 1-4Subarachnoid hemorrhage
  • Track 1-5Transient ischemic attack
  • Track 2-1Embolic strokes
  • Track 2-2Arterial thrombos
  • Track 2-3Cerebral embolism
  • Track 2-4Thrombotic strokes
  • Track 3-1Atherosclerosis
  • Track 3-2Embolism
  • Track 3-3Aneurysm
  • Track 3-4Hypertension
  • Track 3-5Obesity
  • Track 3-6Diabetes
  • Track 4-1Addiction
  • Track 4-2Arachnoid cysts
  • Track 4-3Attention deficit/hyperactivity disorder
  • Track 4-4Autism
  • Track 4-5Bipolar disorder
  • Track 4-6Encephalitis
  • Track 4-7Epilepsy/Seizures
  • Track 4-8Meningitis
  • Track 4-9Migraine
  • Track 4-10Multiple sclerosis
  • Track 4-11Alzheimer
  • Track 5-1Brain stem/Pons
  • Track 5-2Spinal cord neoplasms
  • Track 5-3Astrocytoma
  • Track 5-4Glioma
  • Track 5-5Glioblastoma multiforme
  • Track 5-6Ependymoma
  • Track 6-1Genetics
  • Track 6-2Protein misfolding
  • Track 6-3Protein degradation pathways
  • Track 6-4Programmed cell death
  • Track 6-5Amyotrophic lateral sclerosis
  • Track 6-6Batten disease
  • Track 7-1Atherosclerosi
  • Track 7-2Cardiovascular disease
  • Track 7-3Cancer
  • Track 7-4Arthritis
  • Track 7-5Cataract
  • Track 7-6Osteoporosis
  • Track 7-7Hypertension
  • Track 8-1Ataxia and pain
  • Track 8-2Amyotrophic lateral sclerosis
  • Track 8-3Syringomyelia
  • Track 8-4Traumatic brain injury
  • Track 8-5Neurofibromatosis
  • Track 9-1Anticoagulants/Antiplatelets
  • Track 9-2Antihypertensives
  • Track 9-3Carotid Endarterectomy
  • Track 9-4Angioplasty/Stents
  • Track 10-1Catheter cerebral angiography
  • Track 10-2Doppler Ultrasonography
  • Track 10-3Imaging Techniques
  • Track 10-4Trageted Drug Delivery with Ultrasound
  • Track 11-1CT scans
  • Track 11-2MRI
  • Track 12-1Receptors
  • Track 12-2Ion Channels and Transporters
  • Track 12-3Signaling and synaptic plasticity
  • Track 12-4Sensory Systems
  • Track 12-5Neurobiology of Addiction
  • Track 12-6Neuroprotection and Repair
  • Track 13-1Multiple sclerosis
  • Track 13-2 Randomized
  • Track 13-3Double-blinded
  • Track 13-4Placebo-controlled
  • Track 14-1Strengthening motor skills
  • Track 14-2Mobility training
  • Track 14-3Constraint-induced therapy
  • Track 14-4Range-of-motion therapy
  • Track 14-5Noninvasive brain stimulation
  • Track 14-6Psychological evaluation and treatment
  • Track 14-7Medications
  • Track 14-8Biological therapies
  • Track 14-9Alternative medicine
  • Track 15-1Ischemic cascade
  • Track 15-2Oxidative stress
  • Track 15-3The transcription factor Nrf2
  • Track 15-4Schemia/reperfusion (I/R) injury
  • Track 15-5Post-ischemic inflammation
  • Track 15-6Cytokines and brain inflammation
  • Track 15-7Matrix metalloproteinases
  • Track 15-8Regulatory T lymphocytes